Cargando…
Androgen Receptor Blocker Improves the Cardiometabolic Profile in a Rat Model of Polycystic Ovary Syndrome, but at What Cost?
Introduction: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. PCOS is characterized by androgen excess and ovulatory dysfunction high prevalence of cardiovascular risk factors such as increased blood pressure (BP), insulin resistance (IR), and obe...
Autores principales: | Pruett, Jacob E, Everman, Steven, Fernandez, Edgar David Torres, Davenport, Kacey, Romero, Damian G, Cardozo, Licy L Yanes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089656/ http://dx.doi.org/10.1210/jendso/bvab048.1634 |
Ejemplares similares
-
Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome
por: Pruett, Jacob E., et al.
Publicado: (2021) -
SAT-748 Advantages and Limitations of an Integrative Measurement for All Serum Androgens and Anti-Androgens
por: Schaufele, Fred J, et al.
Publicado: (2020) -
OR07-6 Disrupting DNA-binding Domain Dimerization In The Androgen Receptor In Mice Results In a Partial Androgen Insensitivity Model
por: Claessens, Frank, et al.
Publicado: (2022) -
SAT-010 Adrenal Androgen Synthesis in Aging Men
por: Namba, Aya, et al.
Publicado: (2019) -
SAT-735 Effects of Androgen Receptor Activation on Angiogenesis
por: Huo, Yen-Nien
Publicado: (2020)